Another study led by Qian Tan and collaborators analyzed plasma expression levels of GAS5 from patients with non-small cell lung cancer, and they proposed a combination of GAS5 and CA199 to discriminate early stages of that illness with an area under the curve of 0.734 [30]. This evidence concerns the gene GAS5 and non-small cell lung carcinoma.